Fractyl Labs Announces Positive Clinical Data for First Procedural Therapy to Treat Type 2 Diabetes
September 4, 2014Fractyl Laboratories announced positive clinical data for non-invasive Revita™ Duodenal Mucosal Resurfacing therapy to, the first procedural therapy to treat the underlying causes of insulin resistance in patients with uncontrolled type 2 diabetes.
More »
Veracyte, Inc. to Acquire Allegro Diagnostics, Accelerating Entry Into Pulmonology Market
September 4, 2014Veracyte announced the agreement to acquire Allegro Diagnostics Corp. for $21 million and plans to commercially launch Allegro's lead lung cancer test in the second half of 2015, with meaningful revenue expected in 2017.
More »
Alimera Sciences' ILUVIEN® Receives Tenth National Marketing Authorization For The Treatment Of Chronic Diabetic Macular Edema
September 3, 2014Alimera Sciences announced the Swedish Medical Products Agency has granted marketing authorization to ILUVIEN for the treatment of vision impairment associated with chronic diabetic macular edema (DME).
More »